Richard Saynor

Chief Executive Officer, Sandoz at Novartis AG

Richard Saynor

Richard Saynor

Chief Executive Officer, Sandoz at Novartis AG

Overview
Career Highlights

Sandoz, Inc.
Sandoz International GmbH

RelSci Relationships

1267

Number of Boards

1

Birthday

1967

Age

53

Relationships
RelSci Relationships are individuals Richard Saynor likely has professional access to. A relationship does not necessarily indicate a personal connection.

Group General Counsel of Novartis at Novartis AG

Relationship likelihood: Strong

Chief Executive Officer at Novartis AG

Relationship likelihood: Strong

Chief Financial Officer at Novartis AG

Relationship likelihood: Strong

Chief Digital Officer at Novartis AG

Relationship likelihood: Strong

Division Head, Alcon at Novartis AG

Relationship likelihood: Strong

Head of Novartis Business Services (Nbs) at Novartis AG

Relationship likelihood: Strong

Chief Medical Officer at Novartis AG

Relationship likelihood: Strong

Global Head of Novartis Technical Operations (Nto) at Novartis AG

Relationship likelihood: Strong

Head of Strategic Venture Capital Fund, Pharma Equities at Novartis AG

Relationship likelihood: Strong

Former Global Chief Executive Officer at Novartis AG

Relationship likelihood: Strong

Paths to Richard Saynor
Potential Connections via
Relationship Science
You
Richard Saynor
Chief Executive Officer, Sandoz at Novartis AG
Career History
Chief Executive Officer
2019 - Current

Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ.

Chief Executive Officer
Current

Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria.

Chief Executive Officer, Sandoz
Current

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Richard Saynor. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Richard Saynor's profile does not indicate a business or promotional relationship of any kind between RelSci and Richard Saynor.